Rate of occult metastases in patients (pts) with biochemically-recurrent prostate cancer (BRPC) from a phase 2 trial of sipuleucel-T and androgen deprivation therapy (STAND).
Meeting Abstract
Kibel, Adam S.; Drake, Charles G.; Yu, Evan Y.; Vogelzang, NicholasJ.; Corman, John M.; Karsh, Lawrence Ivan; Elfiky, Aymen; Shore, Neal D.; Millard, Frederick E.; Chang, Nancy N.; Antonarakis, Emmanuel S.